{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:19:43Z","timestamp":1767676783778},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1982,9,1]],"date-time":"1982-09-01T00:00:00Z","timestamp":399686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1982,9]]},"DOI":"10.1007\/bf00296760","type":"journal-article","created":{"date-parts":[[2004,10,6]],"date-time":"2004-10-06T10:44:22Z","timestamp":1097059462000},"page":"41-44","source":"Crossref","is-referenced-by-count":2,"title":["Vindesine: Phase II evaluation in colon cancer and description of its platelet stimulating activity"],"prefix":"10.1007","volume":"9","author":[{"given":"Richard","family":"Pazdur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur H.","family":"Rossof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govind","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Bonomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert E.","family":"Slayton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Wolter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/1097-0142(197910)44:4<1222::AID-CNCR2820440409>3.0.CO;2-X","volume":"44","author":"MA Al-Sarraf","year":"1979","unstructured":"Al-Sarraf MA, Baker L, Talley RW, Kithier K, Vaitkevicius V (1979) The value of serial carcinoembryonic antigen in predicting response rate and survival of patients with gastrointestinal cancer treated with chemotherapy. Cancer 44:1222?1225","journal-title":"Cancer"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJM197408222910802","volume":"291","author":"YS Ahn","year":"1974","unstructured":"Ahn YS, Harrington WJ, Seelman RC, Eytel CS (1974) Vincristine therapy of idiopathic and secondary thrombocytopenias. N Engl J Med 291:376?380","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-3-642-81488-4_13","volume-title":"Cancer Chemo- and Immunopharmacology, vol 1: Chemopharmacology","author":"M Bayssas","year":"1980","unstructured":"Bayssas M, Gouvenia J, de Vassal F, Misset JL, Schwarzenberg L, Ribaud P, Mussett M, Jasmin C, Hayat M, Math\u00e9 G (1980) Vindesine. A new vinca alkaloid. In Math\u00e9 G, Muggia FM (eds) Cancer Chemo- and Immunopharmacology, vol 1: Chemopharmacology. Springer, New York, pp 91?97"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF00257192","volume":"2","author":"AY Bedikian","year":"1979","unstructured":"Bedikian AY, Valdivieso M, Bodey GP, Freireich EJ (1979) Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors. Cancer Chemother Pharmacol 2:263?266","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/1097-0142(19800801)46:3<463::AID-CNCR2820460307>3.0.CO;2-P","volume":"46","author":"AY Bedikian","year":"1980","unstructured":"Bedikian AY, Valdivieso M, Maroun J, Gutterman JV, Hersh EM, Bodey GP (1980) Evaluation of vindesine and MER in colorectal cancer. Cancer 46:463?467","journal-title":"Cancer"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00578560","volume":"5","author":"PD Bonomi","year":"1980","unstructured":"Bonomi PD, Chandra G, Rossof AH, Klaassen D (1980a) Mitomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma. Cancer Chemother Pharmacol 5:39?42","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR7","first-page":"161","volume":"21","author":"P Bonomi","year":"1980","unstructured":"Bonomi P, Rossof AH, Raynor WJ Jr, Quadeer M (1980b) Prediction of survival duration in patients with metastatic measurable colorectal adenocarcinoma. Proc Am Assoc Cancer Res 21:161","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR8","first-page":"1333","volume":"62","author":"VE Currie","year":"1978","unstructured":"Currie VE, Wong PP, Krakoff IH, Young CW (1978) Phase I trial of vindesine in patients with advanced cancer. Cancer Treat Rep 62:1333?1336","journal-title":"Cancer Treat Rep"},{"key":"CR9","first-page":"229","volume":"2","author":"RW Dyke","year":"1979","unstructured":"Dyke RW, Nelson RL, Brade WP (1979) Vindesine. A short review of preclinical data. Cancer Chemother Pharmacol 2:229?232","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00257194","volume":"2","author":"RJ Gralla","year":"1979","unstructured":"Gralla RJ, Tan CTC, Young CW (1979) Vindesine. A review of phase III trials. Cancer Chemother Pharmacol 2:271?274","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0305-7372(80)80004-1","volume":"7","author":"K Hande","year":"1980","unstructured":"Hande K, Gay J, Gober J, Greco FA (1980) Toxicity and pharmacology of bolus vindesine injection and prolonged vindesine infusion. Cancer Treat Rev 7 [Suppl]:25?30","journal-title":"Cancer Treat Rev"},{"key":"CR12","first-page":"41","volume":"15","author":"JM Hill","year":"1961","unstructured":"Hill JM, Loeb E (1961) Treatment of leukemia, lymphoma, and other malignant neoplasms with vinblastine. Cancer Chemother Rep 15:41?61","journal-title":"Cancer Chemother Rep"},{"key":"CR13","first-page":"1258","volume":"33","author":"JF Holland","year":"1973","unstructured":"Holland JF, Scharlau C, Gailaui S (1973) Vincristine treatment of advanced cancer. A cooperative study of 92 cases. Cancer Res 33:1258?1264","journal-title":"Cancer Res"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1365-2141.1977.tb05759.x","volume":"36","author":"CW Jackson","year":"1977","unstructured":"Jackson CW, Edwards CC (1977) Evidence that stimulation of megakaryocytopoiesis by low-dose vincristine results from an effect on platelets. Br J Haematol 36:97?105","journal-title":"Br J Haematol"},{"key":"CR15","first-page":"336","volume":"22","author":"N Kemeny","year":"1981","unstructured":"Kemeny N, Braun D (1981) Advanced colorectal carcinoma: clinical and laboratory parameters as indicators of response and survival. Proc Am Soc Clin Oncol 22:336","journal-title":"Proc Am Soc Clin Oncol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1600-0609.1974.tb00198.x","volume":"12","author":"P Klener","year":"1974","unstructured":"Klener P, Donner L, Hyncica V, Safrankova D (1974) Possible mechanism of vinblastine-induced thrombocytosis. Scand J Haematol 12:179?184","journal-title":"Scand J Haematol"},{"key":"CR17","first-page":"805","volume":"62","author":"G Math\u00e9","year":"1978","unstructured":"Math\u00e9 G, Misset JL, DeVassal F (1978) Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma and Hodgkin's disease. Absence of cross-resistance with vincristine. Cancer Treat Rep 62:805?809","journal-title":"Cancer Treat Rep"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0305-7372(80)80013-2","volume":"7","author":"TP Miller","year":"1980","unstructured":"Miller TP, Jones SE, Chester AB, Dorr RT (1980) Phase II trials of vindesine in breast cancer, lymphoma, and other tumors: Future directions. Cancer Treat Rev 7 [Suppl]:81?86","journal-title":"Cancer Treat Rev"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0305-7372(80)80009-0","volume":"7","author":"RB Natale","year":"1980","unstructured":"Natale RB, Gralla RJ, Wittes RE, Golbey RB, Young CW (1980) Vindesine chemotherapy in lung cancer. Cancer Treat Rev 7:59?63","journal-title":"Cancer Treat Rev"},{"key":"CR20","first-page":"129","volume":"19","author":"T Ohnuma","year":"1978","unstructured":"Ohnuma T, Holland JF, Andrijcuk A (1978) Initial clinical and pharmacologic studies with vindesine. Proc Am Assoc Cancer Res 19:129","journal-title":"Proc Am Assoc Cancer Res"},{"key":"CR21","first-page":"310","volume":"299","author":"S Retsas","year":"1978","unstructured":"Retsas S, Newton KA, Westbury G (1978) Vinca alkaloids and platelets. N Engl J Med 299:310","journal-title":"N Engl J Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0305-7372(80)80014-4","volume":"7","author":"S Retsas","year":"1980","unstructured":"Retsas S, Peat I, Ashford R, Coe M, Maher J, Drury A, Hauham IWF, Philips RH, Newton KA, Westbury G (1980) Updated results of vindesine as a single agent in the therapy of advanced malignant melanoma. cancer Treat Rev 7 [Suppl]:87?90","journal-title":"cancer Treat Rev"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-88-5-627","volume":"88","author":"A Shani","year":"1978","unstructured":"Shani A, O'Connell MJ, Moertel CG, Schutt AJ, Silver A, Go VLW (1978) Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma. Ann Intern Med 88:627?630","journal-title":"Ann Intern Med"},{"key":"CR24","first-page":"1427","volume":"62","author":"IE Smith","year":"1978","unstructured":"Smith IE, Hedley DW, Powers TJ, McElwain TJ (1978) Vindesine: A phase II study in the treatment of breast carcinoma, malignant melanoma and other tumors. Cancer Treat Rep 62:1427?1433","journal-title":"Cancer Treat Rep"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0305-7372(80)80012-0","volume":"7","author":"JE Stambaugh","year":"1980","unstructured":"Stambaugh JE (1980) Phase II trials of vindesine in advanced neoplastic disease. Cancer Treat Rev 7 [Suppl]:75?79","journal-title":"Cancer Treat Rev"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0305-7372(80)80005-3","volume":"7","author":"M Valdivieso","year":"1980","unstructured":"Valdivieso M (1980) Phase I and II studies of vindesine. Cancer Treat Rev 7 [Suppl]:31?37","journal-title":"Cancer Treat Rev"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0305-7372(80)80008-9","volume":"7","author":"CW Young","year":"1980","unstructured":"Young CW (1980) Vindesine trials at Memorial Sloan-Kettering Cancer Center. Cancer Treat Rev 7 [Suppl]:53?57","journal-title":"Cancer Treat Rev"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00296760.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00296760\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00296760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T20:12:45Z","timestamp":1554754365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00296760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1982,9]]}},"alternative-id":["BF00296760"],"URL":"https:\/\/doi.org\/10.1007\/bf00296760","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,9]]}}}